Is Botox Safe? Everything You Need to Know About Safety

The FDA Approval History of Botox

Botox (onabotulinumtoxinA) has one of the most thoroughly documented regulatory histories of any aesthetic treatment. The FDA first approved it in 1989 for the treatment of eye muscle disorders. In 2002, it received landmark approval for cosmetic use — specifically for the temporary improvement of moderate-to-severe frown lines between the eyebrows (glabellar lines) in adults.

Since then, its approved applications have expanded considerably. Botox is now FDA-approved for forehead lines, crow's feet, chronic migraine, excessive sweating (hyperhidrosis), overactive bladder, muscle spasticity, and cervical dystonia. This breadth of approved uses reflects the depth of clinical evidence supporting its safety and efficacy.

Competing products — Dysport, Xeomin, Jeuveau, and Daxxify — have also received FDA approval and undergo the same rigorous review process. At Aurelia, we select the formulation best suited to each patient's anatomy and treatment goals.

How Botox Works: Understanding the Mechanism

Botox is a purified form of botulinum toxin type A. When injected into a targeted muscle in tiny, precise doses, it temporarily blocks the nerve signals that cause that muscle to contract. The result is a controlled, temporary relaxation of the muscle — smoothing overlying wrinkles and preventing new lines from forming through repeated expression.

The key word is temporary. Botox does not enter the bloodstream in meaningful quantities at cosmetic doses. It acts locally at the injection site, and its effects gradually wear off over three to six months as the nerve endings regenerate. This reversibility is an important part of its safety profile.

Safety Record: What the Data Shows

With over 25 years of cosmetic use and more than 100 million treatments performed annually worldwide, Botox has an extraordinarily well-documented safety record. Large-scale post-market surveillance studies consistently show serious adverse events to be very rare — estimated at less than 1 in 10,000 treatments when performed by qualified injectors.

A 2021 review published in the journal Aesthetic Surgery Journal analyzed data from over 36,000 cosmetic Botox treatments and found a serious complication rate of under 0.01%. The vast majority of adverse events reported were mild and transient — the kind described below under common side effects.

Common Side Effects (Mild and Temporary)

Most side effects from Botox are minor and resolve within a few days to two weeks. These include:

• Injection site reactions: Redness, mild swelling, or slight bruising at the needle entry point — typically fading within 24–48 hours.
• Headache: Mild headache affects a small percentage of patients and usually resolves within 24 hours.
• Temporary heaviness: A feeling of slight heaviness around treated areas, particularly the forehead, which fades as the product settles.
• Asymmetry: Occasionally the product distributes unevenly, but this can usually be corrected with a small touch-up at your two-week review.

Who Should NOT Get Botox

While Botox is safe for the vast majority of healthy adults, there are specific contraindications that must be assessed during a proper medical consultation. You should not receive Botox if you:

• Are pregnant or breastfeeding. The safety of botulinum toxin during pregnancy and lactation has not been established. Aurelia will always decline to treat patients who are pregnant or nursing, without exception.
• Have a neuromuscular disorder. Conditions including myasthenia gravis, Lambert-Eaton syndrome, or ALS increase the risk of serious adverse events. Patients with these conditions are not candidates for Botox.
• Are taking certain medications. Aminoglycosides, quinine, and some other drugs can potentiate the effect of botulinum toxin. A thorough medication review is conducted at every consultation.
• Have an active infection at the injection site. Treating through active skin infection risks spreading bacteria. Treatment must be deferred until the infection resolves.
• Have a known allergy to botulinum toxin or to albumin (human serum albumin is used in some formulations).

This is precisely why Botox should always be administered by — or under the direct supervision of — a licensed physician who can take a complete medical history and identify contraindications before treatment begins.

Why the Injector Makes All the Difference

The most important safety variable in any Botox treatment is not the product — it is the person holding the syringe. A deep knowledge of facial anatomy, injection technique, dosing, and patient assessment are skills developed over years of clinical practice and are simply not transferable to a weekend course.

Botox injected in the wrong plane, at the wrong depth, or in the wrong location can migrate into adjacent muscles — causing the eyelid drooping, brow asymmetry, and unnatural expressions that make headlines. These are almost always avoidable complications when proper technique is applied.

The proliferation of discount "Botox parties," medical spas staffed by minimally trained practitioners, and non-physician injectors has dramatically increased the rate of avoidable complications. The FDA and the American Society for Dermatologic Surgery both recommend that Botox be administered by board-certified physicians or under their direct, in-room supervision.

How Aurelia Ensures the Highest Safety Standards

At Aurelia Aesthetics, every Botox treatment is performed by a board-certified dermatologist or plastic surgeon with fellowship training — never a nurse practitioner or aesthetician acting independently. Our approach to safety is built around three pillars:

The bottom line: Botox, in the right hands, is a safe, predictable, and highly effective treatment. Choosing a qualified injector at a reputable medical clinic is the single most important decision you can make to protect both your safety and your results.